Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 1/2 1Phase 1 1

Status

Unknown 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1Dermatologic 1

Conditions

Spondylitis, Ankylosing 1Psoriasis 1Melanoma 1Lymphoma, Follicular 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × secukinumab × Clear all
NCT07237594 2026-06-04

REPLAY

Duke University

Phase 1 Recruiting
4 enrolled
Dermatologic

Melanoma

NCT06833112 2025-02-18

Interleukin-17 (IL-17) Inhibitor in Combination With Tumor Necrosis Factor α (TNFα )Inhibitor for the Treatment of Ankylosing Spondylitis

The Affiliated Hospital Of Guizhou Medical University

Phase 4 Not yet recruiting
10 enrolled

Spondylitis, Ankylosing

NCT04571567 2022-04-11

A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis

Icahn School of Medicine at Mount Sinai

Phase 4 Completed
20 enrolled
Lymphoid

Lymphoma, Follicular, Psoriasis

NCT04298320 2020-03-16

A Trial of SHR-1210 in Combination With AIN457 in Patients With MSS CRC(SHR-1210-AIN457)

Harbin Medical University

Phase 1/2 Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡